![Global Liquid Biopsy Market](https://res.cloudinary.com/devmoveo/image/upload/v1684747581/skyquest/gallery/Global-Liquid-Biopsy-Market.jpg)
Report ID: SQMIG35J2060
Report ID:
SQMIG35J2060 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|
Tables:
61 |
Figures:
75
North America is the dominant region. This can be attributed to the high prevalence of cancer in the region, coupled with the increasing adoption of advanced diagnostic technologies. The US is the major contributor to the North American market. According to the American Cancer Society, lung cancer is the leading cause of cancer-related deaths in the US, and liquid biopsy tests are gaining popularity for early cancer detection.
However, the Asia-Pacific region is expected to witness the fastest growth in the liquid biopsy market due to the increasing awareness regarding cancer and its early detection, coupled with the rising investments in healthcare infrastructure, is driving the market growth in this region. Countries like China and Japan are the major contributors to the APAC liquid biopsy market. For instance, China has a high burden of lung cancer, and the government has initiated various programs to promote early cancer detection and treatment.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2060